| |
Content
|
Modern Medicine and Traditional Chinese Medicine - Diabetes Mellitus
Traditional Chinese Medicine and Diabetes - Herbal
Medicine Treatment
While acupuncture is a distinctive feature of traditional
Chinese medicine, China's herbal medicine has many parallels to, and is a part
of the general quest for effective medicines to treat illness. Chinese ancestors
recognized their dependence upon nature in both health and sickness. Led by
instinct, taste and experience, they used plants, animal parts and minerals that
did not belong to their usual diet. Until well into the 20th century, much of
the pharmacopoeia of scientific medicine was derived from just this type of
herbal lore. Today in the United States, about one quarter of the prescriptions
dispensed by pharmacies contain at least one active ingredient derived from
plant material.
The 20th century has also seen a revival of more natural medicine as an outcome
of increasing disenchantment with conventional medicine. By utilizing natural
substances together in their whole form in accurate formulations, effectiveness
will be maximized and side effects minimized. This is contrary to conventional
medicine that extracts or synthesizes active chemicals that often, over time,
produce drastic side effects due to their partiality.
Yu Xiao San 8805
Designed to restore pancreatic function and to proliferate
insulin beta cells, Yu Xiao San has been shown to gradually and effectively
lower blood-sugar levels and increase insulin secretion. In addition it has been
shown to regulate carbohydrate metabolism, improve blood circulation, lower
blood cholesterol and increase immune response. The main herb components are
Ramulus Euonymi Alatae, Niu Bang Zi (Fructus Arctii Lappae), Wei Ling Xian
(Radix Clemetidis Chinensis), Di Gu Pi (Cortex Lycii Chinensis Radicis), E Zhu (Rhizoma
Curcumae Zedoariae), Jie Geng (Radix Platycodi Grandiflori), Li Zhi He (Semen
Litchi Chinensis) and Ren Shen (Radix Ginseng). This patent is currently also
being produced in the US and marketed as a health food. (see Appendix-Clinical
Research).
Clinical Report
From Feb. 1992 to Oct. 1992, 10,618 cases were selected based
upon the diagnostic criteria established for diabetes mellitus by the World
Health Organization. The patients were drawn for clinical assessment from the
China Beijing Chao Yang District Red Cross Hospital and from 48 comparable
hospitals nationwide.
Treatment Criteria and Result
Clinical Recovery: The preferred criterion: FPG (Fasting Plasma Glucose) <6.1
mmol/L (110 mg/dl), HbA1c <6.8%; symptoms and complications recovery;
discontinuing medication after 3 months or more.
Prominent Effect: FPG <7.8 mmol/L (140 mg/dl), HbA1c <8%; symptoms improved and
complications reduced.
Effective: FPG reduced 3.33 mmol/L (60 mg/dl), HbA1c <9%.
Ineffective: No evidence of symptom improvement and reduction of criteria
established for diabetes mellitus.
Results
After 4 months of treatment and monitoring, of patients with
Type 1 diabetes, 84 (6.80%) demonstrated clinical recovery, 106 (8.58%)
prominent effect, 144 (11.65%) some effect, and 902 (72.98%) no effect. Over the
same period, 1794 (19.12%) patients with Type 2 diabetes demonstrated clinical
recovery, 2346 (25.01%) prominent effect, 3835 (40.88%) some effect, and 1407
(15.00%) no effect. Overall totals were 1,878 (17.69%), 2,452 (23.09%), 3,979
(37.47%) and 2,309 (21.75%) respectively.
Two Case Reports
Mrs. W.
Age: 56; height: 5'6"; weight: 150 lbs.
1990.5: Tested blood glucose at 200mg/dl, diagnosed as Diabetes II, took oral
hypoglycaemics two tablets twice a day.
1994.9.10: Began treatment with Yu Xiao San 8805 two tablets four times a day,
and continued oral hypoglycaemics.
1994.9.25: FPG level at 140-160mg/dl.
1994.10.12: FPG was 112-140/dl. Reduced oral hypoglycaemics to one tablet.
1994.11.12: Stopped oral hypoglycaemics. Fasting blood glucose was 93-136mg/dl.
1994.12.12: FPG was 90-128mg/dl. Continued Yu Xiao San for three months for
consolidation.
Up to 1995.8: Monthly monitored blood glucose level 100-110mg/dl.
Mr. G.
Age: 44; height: 5'7"; weight: 152 lbs.
1990.6: Rapid weight loss, tested blood glucose at 405mg/dl, diagnosed as
Diabetes I, hospitalised on insulin injection, 20 units once a day.
1992.8.20: FPG was 117mg/dl. Started Yu Xiao San 8805 two tablets four times a
day and continued injection.
1992.9.5: FPG 115-120mg/dl.
1992.10.5: FPG 105-109mg/dl, lower blood sugar reaction. Reduced insulin 4
units.
1992.10.29: FPG 90-111mg/dl. Reduced insulin 4 units.
1992.11.20: FPG 95-115mg/dl. Reduced insulin 2 units.
1993.1.15: FPG 90-120mg/dl. Stopped injection and continued Yu Xiao San 8805 two
tablets four times a day for three month consolidation.
Up to 1995.8: Maintained blood glucose level 90-140mg/dl after discontinuance of
any medication.
Yu Xiao San 8805 was developed by Dr. Lianjin Chong, Director of The Red Cross
Hospital in Beijing, as a herbal product to restore pancreatic function and to
increase insulin beta cells. It has undergone experimental tests both in China
and the United States with good results and has been used by diabetics in over
fifty countries worldwide. No adverse or allergic reactions have been reported
from its use nor has damage to the liver, kidney or any other organs. It is
currently used by the Asian Diabetes Association, Red Cross Hospital in Beijing
and several State Hospitals in China as a medical treatment for Type II
Diabetes. For a more complete description of Yu Xiao San together with numerous
other case reports refer to http://www.cljhealth.com
|
|
